SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Francesco Porpiglia, Francesco Cantiello, Stefano De Luca, Matteo Manfredi, Andrea Veltri, Filippo Russo, Antonino Sottile, Rocco Damiano, In-parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance, BJU International, 2016, 117, 2
  2. You have free access to this content2
    Baris Turkbey, Anna M. Brown, Sandeep Sankineni, Bradford J. Wood, Peter A. Pinto, Peter L. Choyke, Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer, CA: A Cancer Journal for Clinicians, 2016, 66, 1
  3. 3
    Dževad Belkić, Karen Belkić, The fast Padé transform for noisy magnetic resonance spectroscopic data from the prostate: potential contribution to individualized prostate cancer care, Journal of Mathematical Chemistry, 2016, 54, 3, 707

    CrossRef

  4. 4
    Thomas J. Guzzo, Prostate Cancer, 2016,

    CrossRef

  5. 5
    Pranav Sharma, Kamran Zargar-Shoshtari, Julio M Pow-Sang, Biomarkers for prostate cancer: present challenges and future opportunities, Future Science OA, 2015,

    CrossRef

  6. 6
    Guillaume Ploussard, Hendrik Isbarn, Alberto Briganti, Prasanna Sooriakumaran, Christian I. Surcel, Laurent Salomon, Massimo Freschi, Cristian Mirvald, Henk G. van der Poel, Anna Jenkins, Piet Ost, Inge M. van Oort, Ofer Yossepowitch, Gianluca Giannarini, Roderick C.N. van den Bergh, Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 2, 71.e1

    CrossRef

  7. 7
    M. Minhaj Siddiqui, Hong Truong, Soroush Rais-Bahrami, Lambros Stamatakis, Jennifer Logan, Annerleim Walton-Diaz, Baris Turkbey, Peter L. Choyke, Bradford J. Wood, Richard M. Simon, Peter A. Pinto, Clinical Implications of a Multiparametric Magnetic Resonance Imaging Based Nomogram Applied to Prostate Cancer Active Surveillance, The Journal of Urology, 2015, 193, 6, 1943

    CrossRef

  8. 8
    Irene A. Burger, Debra A. Goldman, Hebert Alberto Vargas, Michael W. Kattan, Changhon Yu, Lei Kou, Vaagn Andikyan, Dennis S. Chi, Hedvig Hricak, Evis Sala, Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer, Gynecologic Oncology, 2015, 138, 3, 554

    CrossRef

  9. 9
    Zachary Klaassen, Abhay A. Singh, Lauren E. Howard, Zhaoyong Feng, Bruce Trock, Martha K. Terris, William J. Aronson, Matthew R. Cooperberg, Christopher L. Amling, Christopher J. Kane, Alan Partin, Misop Han, Stephen J. Freedland, Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?, Cancer, 2015, 121, 9
  10. 10
    Ivo G. Schoots, Neophytos Petrides, Francesco Giganti, Leonard P. Bokhorst, Antti Rannikko, Laurence Klotz, Arnauld Villers, Jonas Hugosson, Caroline M. Moore, Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review, European Urology, 2015, 67, 4, 627

    CrossRef

  11. 11
    Adil Ouzzane, Raphaele Renard-Penna, François Marliere, Pierre Mozer, Jonathan Olivier, Johann Barkatz, Philippe Puech, Arnauld Villers, Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients Considered for Active Surveillance for Clinically Low Risk Prostate Cancer Based on Systematic Biopsies, The Journal of Urology, 2015, 194, 2, 350

    CrossRef

  12. 12
    Seyed Saeid Dianat, H. Ballentine Carter, Kenneth J. Pienta, Edward M. Schaeffer, Patricia K. Landis, Jonathan I. Epstein, Bruce J. Trock, Katarzyna J. Macura, Magnetic Resonance–invisible Versus Magnetic Resonance–visible Prostate Cancer in Active Surveillance: A Preliminary Report on Disease Outcomes, Urology, 2015, 85, 1, 147

    CrossRef

  13. 13
    Sangjun Yoo, Jeong Kon Kim, In Gab Jeong, Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists, Korean Journal of Urology, 2015, 56, 7, 487

    CrossRef

  14. 14
    Valeria Panebianco, Flavio Barchetti, Alessandro Sciarra, Antonio Ciardi, Elena Lucia Indino, Rocco Papalia, Michele Gallucci, Vincenzo Tombolini, Vincenzo Gentile, Carlo Catalano, Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 1, 17.e1

    CrossRef

  15. 15
    Lars Boesen, Elizaveta Chabanova, Vibeke Løgager, Ingegerd Balslev, Kari Mikines, Henrik S. Thomsen, Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology, European Radiology, 2015, 25, 6, 1776

    CrossRef

  16. 16
    Andrew S. Behesnilian, Robert E. Reiter, Risk stratification of prostate cancer in the modern era, Current Opinion in Urology, 2015, 25, 3, 246

    CrossRef

  17. 17
    Robert R. Flavell, Antonio C. Westphalen, Carmin Liang, Christopher C. Sotto, Susan M. Noworolski, Daniel B. Vigneron, Zhen J. Wang, John Kurhanewicz, Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance, Abdominal Imaging, 2014, 39, 5, 1027

    CrossRef

  18. 18
    Matthias C. Roethke, Michaela Kniess, Sascha Kaufmann, Matthias P. Lichy, Heinz-Peter Schlemmer, Arnulf Stenzl, David Schilling, Can high-spatial resolution T2-weighted endorectal MRI rule out clinically significant prostate cancer?, World Journal of Urology, 2014, 32, 2, 379

    CrossRef

  19. 19
    Debasish Sundi, Vinson Wang, Phillip M. Pierorazio, Misop Han, Alan W. Partin, Phuoc T. Tran, Ashley E. Ross, Trinity J. Bivalacqua, Identification of men with the highest risk of early disease recurrence after radical prostatectomy, The Prostate, 2014, 74, 6
  20. 20
    Thiele Kobus, Alan J. Wright, Tom W. J. Scheenen, Arend Heerschap, Mapping of prostate cancer by 1H MRSI, NMR in Biomedicine, 2014, 27, 1
  21. 21
    Daniel J. Lee, Hashim U. Ahmed, Caroline M. Moore, Mark Emberton, Behfar Ehdaie, Multiparametric Magnetic Resonance Imaging in the Management and Diagnosis of Prostate Cancer: Current Applications and Strategies, Current Urology Reports, 2014, 15, 3

    CrossRef

  22. 22
    Seyed Saeid Dianat, H. Ballentine Carter, Katarzyna J. Macura, Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 1, 39.e1

    CrossRef

  23. 23
    R. J. Caras, Joseph R. Sterbis, Prostate Cancer Nomograms: A Review of Their Use in Cancer Detection and Treatment, Current Urology Reports, 2014, 15, 3

    CrossRef

  24. 24
    Amita Shukla-Dave, Hedvig Hricak, Role of MRI in prostate cancer detection, NMR in Biomedicine, 2014, 27, 1
  25. 25
    Leonardo O. Reis, Athanase Billis, Stenio C. Zequi, Marcos Tobias-Machado, Publio Viana, Michael Cerqueira, John F. Ward, Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts (“ICE”), The Aging Male, 2014, 17, 2, 66

    CrossRef

  26. 26
    David M. Marcus, Peter J. Rossi, Sherif G. Nour, Ashesh B. Jani, The Impact of Multiparametric Pelvic Magnetic Resonance Imaging on Risk Stratification in Patients With Localized Prostate Cancer, Urology, 2014, 84, 1, 132

    CrossRef

  27. 27
    François Marliere, Philippe Puech, Ahmed Benkirane, Arnauld Villers, Laurent Lemaitre, Xavier Leroy, Nacim Betrouni, Adil Ouzzane, The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer, World Journal of Urology, 2014, 32, 4, 951

    CrossRef

  28. 28
    Lambros Stamatakis, M. Minhaj Siddiqui, Jeffrey W. Nix, Jennifer Logan, Soroush Rais-Bahrami, Annerleim Walton-Diaz, Anthony N. Hoang, Srinivas Vourganti, Hong Truong, Brian Shuch, Howard L. Parnes, Baris Turkbey, Peter L. Choyke, Bradford J. Wood, Richard M. Simon, Peter A. Pinto, Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer, Cancer, 2013, 119, 18
  29. 29
    Allison S. Glass, Sanoj Punnen, Matthew R. Cooperberg, Divorcing Diagnosis From Treatment: Contemporary Management of Low-Risk Prostate Cancer, Korean Journal of Urology, 2013, 54, 7, 417

    CrossRef

  30. 30
    Michael S. Borofsky, Andrew B. Rosenkrantz, Nitya Abraham, Rajat Jain, Samir S. Taneja, Does Suspicion of Prostate Cancer on Integrated T2 and Diffusion-weighted MRI Predict More Adverse Pathology on Radical Prostatectomy?, Urology, 2013, 81, 6, 1279

    CrossRef

  31. 31
    Kinzya Grant, Maria L. Lindenberg, Haytham Shebel, Yuxi Pang, Harsh K. Agarwal, Marcelino Bernardo, Karen A. Kurdziel, Baris Turkbey, Peter L. Choyke, Functional and molecular imaging of localized and recurrent prostate cancer, European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40, S1, 48

    CrossRef

  32. 32
    B. Turkbey, E. Mena, O. Aras, B. Garvey, K. Grant, P.L. Choyke, Functional and Molecular Imaging: Applications for Diagnosis and Staging of Localised Prostate Cancer, Clinical Oncology, 2013, 25, 8, 451

    CrossRef

  33. 33
    Behfar Ehdaie, Shahrokh F. Shariat, Magnetic Resonance Imaging–Targeted Prostate Biopsy: Back to the Future, European Urology, 2013, 63, 1, 141

    CrossRef

  34. 34
    Mahyar Ghafoori, Manijeh Alavi, Mounes Aliyari Ghasabeh, MRI in Prostate Cancer, Iranian Red Crescent Medical Journal, 2013, 15, 12

    CrossRef

  35. You have free access to this content35
    Hashim U. Ahmed, Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance, BJU International, 2013, 111, 7
  36. 36
    Albert El Hajj, Guillaume Ploussard, Alexandre Taille, Yves Allory, Dimitri Vordos, Andras Hoznek, Claude Clément Abbou, Laurent Salomon, Patient selection and pathological outcomes using currently available active surveillance criteria, BJU International, 2013, 112, 4
  37. 37
    Baris Turkbey, Haresh Mani, Omer Aras, Jennifer Ho, Anthony Hoang, Ardeshir R. Rastinehad, Harsh Agarwal, Vijay Shah, Marcelino Bernardo, Yuxi Pang, Dagane Daar, Yolanda L. McKinney, W. Marston Linehan, Aradhana Kaushal, Maria J. Merino, Bradford J. Wood, Peter A. Pinto, Peter L. Choyke, Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?, Radiology, 2013, 268, 1, 144

    CrossRef

  38. 38
    Lian-Ming Wu, Jian-Rong Xu, Jiani Hu, Reply, American Journal of Roentgenology, 2013, 200, 2, W220

    CrossRef

  39. You have free access to this content39
    James Thompson, Nathan Lawrentschuk, Mark Frydenberg, Les Thompson, Phillip Stricker, The role of magnetic resonance imaging in the diagnosis and management of prostate cancer, BJU International, 2013, 112,
  40. You have free access to this content40
    Oguz Akin, Sandra B. Brennan, D. David Dershaw, Michelle S. Ginsberg, Marc J. Gollub, Heiko Schöder, David M. Panicek, Hedvig Hricak, Advances in oncologic imaging, CA: A Cancer Journal for Clinicians, 2012, 62, 6
  41. 41
    Behfar Ehdaie, Expectant Management of Localized Prostate Cancer—Who, What, When, Where and How?, The Journal of Urology, 2012, 188, 3, 696

    CrossRef

  42. 42
    Adam J. Jung, Antonio C. Westphalen, Imaging Prostate Cancer, Radiologic Clinics of North America, 2012, 50, 6, 1043

    CrossRef

  43. 43
    Hebert Alberto Vargas, Oguz Akin, Amita Shukla-Dave, Jingbo Zhang, Kristen L. Zakian, Junting Zheng, Kent Kanao, Debra A. Goldman, Chaya S. Moskowitz, Victor E. Reuter, James A. Eastham, Peter T. Scardino, Hedvig Hricak, Performance Characteristics of MR Imaging in the Evaluation of Clinically Low-Risk Prostate Cancer: A Prospective Study, Radiology, 2012, 265, 2, 478

    CrossRef

  44. 44
    A. S. Glass, M. R. Cooperberg, M. V. Meng, P. R. Carroll, Role of Active Surveillance in the Management of Localized Prostate Cancer, JNCI Monographs, 2012, 2012, 45, 202

    CrossRef